Global Oncology Leadership Team
Comprised of Takeda's global oncology commercial operations, Takeda Oncology operates in close alignment with Takeda's dedicated global oncology R&D function, the Oncology Therapeutic Area Unit (OTAU) and Takeda's Oncology Drug Discovery Unit to drive forward the company's products while maintaining a focus on expanding our oncology pipeline.
The organizational structure and governance model for Takeda Oncology is designed to drive customer proximity, nimbleness, agility and accountability. Consistent with these principles, Takeda Oncology operates with a relatively flat organization that allows close proximity to our patients and customers, so that we can deeply understand their unique and changing needs and address them.
The Takeda Oncology organization is comprised of the following functions and led by the following individuals:
CHRISTOPHE BIANCHI, M.D.
President, Global Oncology Business Unit
ALESSANDRO "MILLER" BOCALON
Head, Human Resources, Global Oncology Business Unit & Boston Corp Functions
CHRIS CLAIBORNE, Ph.D.
Head, Oncology Drug Discovery Unit
Vice President, U.S. Market Access
Vice President, U.S. Marketing, Operations & Analytics
Head, Finance, Global Oncology Business Unit
Head, Takeda Boston and Global Oncology Communications
Chief Counsel, Global Oncology Business Unit and Head, Patient Advocacy
Head, Japan Oncology Business Unit
LIVIU NICULESCU, M.D., Ph.D.
Vice President, Oncology Global Medical Affairs
Vice President, U.S. Operations
Vice President, Strategic Planning & Global Brand Head, ADCETRIS
Vice President, Global PMAHE (Pricing, Market Access & Health Economics), Pipeline, and Planning
Vice President, U.S. Sales
Interim Head, Oncology Therapeutic Area Unit
Head, Compliance, Global Oncology Business Unit
Head, Europe Oncology Business Unit